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Aortic Debris and
Coronary Guiding Catheters
I read with interest the recent article by Keeley and Grines
regarding scraping of aortic debris by coronary guiding catheters.
This has been a problem for all interventional cardiologists, and it
is rewarding to see this issue addressed in a quantitative fashion in
this publication. We have had experiences similar to those of the
authors in identifying atheromatous debris, particularly with the
use of left coronary guiding catheters.
There are several issues not addressed in the article that I believe
deserve mention. First, it has been our experience that the larger
bore guide catheters cause release of more atheromatous debris.
There seems to be a noticeable increase when switching from 8 fr
to 9 fr guides.
Second, a method of minimizing or avoiding the scraping of
aortic debris is the insertion of an obturator inside the guiding
catheter. The one that we commonly use is a DVI introducing
catheter, which is 110 cm long. For a 9-fr guide, we use a 7-fr
obturator. For an 8 fr guide, we use a 6 fr obturator. An
alternative would be the use of a 110 or 125 cm diagnostic
multipurpose catheter to serve as an obturator. With the use of
the obturator, there is a smooth transition from the wire to the
guiding catheter and thus, the amount of aortic debris is
significantly reduced.
In our experience, the most voluminous release of debris is
during renal artery stenting procedures. Many of these patients
have diffuse aortic atherosclerosis and the shape of the renal artery
guide catheters is extremely conducive to scraping of aortic debris.
Again, we have found that the use of obturators significantly
minimizes this effect.
Fred M. Krainin, MD, FACC
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In our practice, the trend has been to downsize guiding catheter
size as well as femoral sheath size. From the start of this
prospective analysis, newer balloon and stent designs have made
the use of 6 and 7 F guiding catheters technically feasible and
desirable. Only 80 catheters of the 1,000 catheters evaluated were
9 or 10 F in size (0.08%); most were 8 F. When this small
subgroup was analyzed, there was no statistically significant dif-
ference in the amount of debris collected. This may be primarily a
result of a small sample size.
We believe that most aortic scraping occurs due to catheter
shape, particularly the extent of the secondary bend. This is
perhaps why in your practice Krainin et al. have noted increased
debris collection with the use of renal artery guiding catheters.
Properly sized obturators not only fill the lumen, but also
straighten the curves of the guiding catheter making it less likely to
scrape the aorta. Although we routinely use obturators with large
bore (10 F) guiding catheters, we do not do so with 8 and 9 F
guiding catheters. It is unclear whether the use of obturators may
actually hinder the exit of the debris from the guiding catheter and
lead to increased risk of embolization.
Cindy L. Grines, MD
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ST Elevation Secondary
to Microvascular Dysfunction
Murakami and colleagues (1) recently described three cases of
spontaneous ST elevation in patients with angiographic normal
coronary arteries and implicated microvascular dysfunction as the
cause of the transmural ischemia. This hypothesis is valid if large
vessel coronary spasm has been adequately excluded. Two aspects
of their report require further clarification before this can be
satisfied (1). The serial electrocardiograms (ECGs) that reported
ST elevation also demonstrated T wave inversion, an early ECG
sign of reperfusion. Thus, the angiographic snapshot may have
unfortunately been taken after resolution of the transient coronary
spasm (2). The acetylcholine provocation test used to exclude
coronary spasm appears to have been performed after high-dose
intracoronary nitrates, thereby potentially inhibiting the spastic
response. If these details have been addressed, the findings of
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Murakami are interesting and warrant the question of the role of
the microvasculature in other syndromes associated with ST
elevation, such as acute myocardial infarction.
In a study of the coronary slow flow phenomenon (angiographi-
cally normal coronary arteries with Thrombolysis in Myocardial
Infarction trial [TIMI-2] flow) (2) we have observed similar
findings to those of Murakami et al. During coronary hemody-
namic studies to determine the pathophysiology of this disorder,
we infused intracoronary acetylcholine into eight patients in the
absence of vasodilator therapy. In one patient, the infusion
provoked chest pain with ST elevation in the absence of
epicardial arterial spasm. We would therefore be interested to
know if any of the three cases observed by Murakami et al. had
evidence of the coronary slow flow phenomenon. The coronary
Doppler flow velocity measurements would suggest that at least
one patient may.
Surprisingly, our patient with ST elevation showed no prolon-
gation in the TIMI-frame count; an observation consistent with
Murakami’s findings from the coronary Doppler flow velocities.
Furthermore, there was no evidence of nett lactate production.
These observations may reflect the limitations of the techniques
utilized, or may alternatively demonstrate that ST segment
changes may be independent of myocardial ischemia (3). Further
studies of uncommon patients such as these may provide further
insight into the mechanism of ST elevation.
John F. Beltrame, BSc, BMBS, FRACP
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The phenomenon of ST-segment elevation with normal coronary
angiography may be rarely observed in many institutions in the
world where coronary angiography is routinely performed. To
explain the mechanism for this strange phenomenon, microvascu-
lar constriction has been suspected, but no clear evidence has yet
been provided. Our study (where we used a Doppler guide wire)
provided new evidence, and we proposed the novel hypothesis of
inappropriate microvascular constriction to explain this phenom-
enon (1). It is still not clear whether microvascular spasm as
described by some authors (2–5) certainly took place during this
phenomenon. We still doubt that microvascular “spasm” is a
pathogenetic cause of this phenomenon because there is no
concrete evidence demonstrating its occurrence. It is still possible
that microvascular constriction during the phenomenon is one of
the physiologic responses in the local area, however, the pathologic
manifestation can be seen in the whole heart.
To understand this phenomenon, the most important point
would be whether it indicated cardiac ischemia, as Drs. Beltrame
and Horowitz questioned. In our three patients, only two episodes
in one patient (case 1) showed biphasic T wave after restoration of
ST-segment. Both of these episodes persisted for over 15 min, but
the other patients had the phenomenon within 5 min. The T wave
inversion after ST-segment elevation was sometimes observed
during PTCA. However, no obvious T wave inversion was
observed when coronary occlusion time by angioplasty was sub-
stantially short. We currently have 10 episodes of ST-segment
elevation in 9 patients (unpublished data). In these patients, only
three episodes of biphasic T wave were observed in 2 patients, but
no T wave inversion was observed. However, all of the 9 patients
except one (patient 3 in our study) had severe chest pain during
ST-segment elevation, and this chest pain was relieved after
ST-segment had been restored, which may reflect cardiac isch-
emia.
Eight of 10 episodes had increased TIMI frame count, but two
had a similar count compared with control angiography. The
TIMI frame count during ST-segment elevation did not always
show similar changes. The phenomenon of our patients was very
similar to the study by Beltrame et al. (6). Although all of our three
reported patients underwent intracoronary acetylcholine infusion
test to provoke epicardial coronary spasm, one episode occurred in
patient 1 before any drug infusion. The other three episodes took
place after intracoronary acetylcholine infusion, not after nitroglyc-
erin infusion, but the phenomenon was not observed immediately
after acetylcholine infusion. There was significant time delay
between ST-segment elevation and intracoronary acetylcholine
infusion. Currently, half of 10 episodes were observed before either
acetylcholine infusion or any other drug challenge.
Surprisingly, in our 10 episodes, two exhibited the phenomenon
before initial angiography. The phenomenon was observed just
after coronary catheter insertion. This fact suggested that iatro-
genic microemboli through a catheter as a cause of the phenom-
enon may possibly be discounted.
Hironori Murakami, MD, PhD
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